Search - tctmd.com

Displaying 181 - 200 of 2580

Sort: Relevancy | Date

Presentation TCT 2016

The TAVR Development Journey: Lessons Learned and Drivers of Success

Presenter: John G. Webb, Ajit Yoganathan

October 30, 2016

Presentation TCT 2016

Intermediate-Risk Studies II: Updates From SURTAVI

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Jeffrey J. Popma

October 30, 2016

Presentation TCT 2016

Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Susheel K. Kodali

October 30, 2016

Presentation TCT 2016

Real-world Requirements and Expectations for TAVR in Lower Risk Patients

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Martin B. Leon

October 30, 2016

Presentation TCT 2016

Flash Debate: Counterpoint - Guidelines Have Limited Value in Rapidly Evolving Transcatheter Valve Therapies!

Presenter: Patrick T. O'Gara, Alec S. Vahanian, John G. Webb

October 30, 2016

Presentation TCT 2016

Flash Debate: Point Guidelines Should Remain the Standard for Clinical Practice!

Presenter: Patrick T. O'Gara, Alec S. Vahanian

October 30, 2016

Presentation TCT 2016

An Interesting Alternative: The New WikiRecs for TAVR Use in Lower Risk Patients

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Catherine M. Otto

October 30, 2016

Presentation TCT 2016

Future TAVR Guidelines: The Next ACC/AHA TAVR Focused Update and New Appropriate Use Criteria for TAVR

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Samir R. Kapadia

October 30, 2016

Presentation TCT 2016

My Thoughts on TAVR Valve-in-Valve Procedures

Presenter: Georgios Sianos, Milan A. Nedeljkovic

October 30, 2016

Presentation TCT 2016

Case Reviews: TAVR Valve-in-Valve

Presenter: Georgios Sianos, Matjaz Bunc

October 30, 2016

Presentation TCT 2016

TAVR in Patients With Poor Femoral Access

Presenter: Neal S. Kleiman, Patrick T. O'Gara, Richard Smalling

October 30, 2016

Presentation TCT 2016

Severe AS and Extreme Co-morbidities (Futile Patient?)

Presenter: Neal S. Kleiman, Patrick T. O'Gara, Suzanne V. Arnold

October 30, 2016

Presentation TCT 2016

Case #5: Suboptimal Transcatheter Treatment of Failed Prior Surgical Mitral Repair

Presenter: Stanley J. Chetcuti, Susheel K. Kodali, Vinayak Bapat

October 30, 2016

Presentation TCT 2016

Management of Failing Aortic Bioprosthesis

Presenter: Neal S. Kleiman, Patrick T. O'Gara, Danny Dvir

October 30, 2016

Presentation TCT 2016

Case #4: Transseptal Transcatheter Treatment of Failed Mitral Bioprosthesis (With Tips and Tricks)

Presenter: Stanley J. Chetcuti, Susheel K. Kodali, Christian Spies

October 30, 2016

Presentation TCT 2016

TAVR in Patients With Atrial Fibrillation

Presenter: Neal S. Kleiman, Patrick T. O'Gara, Fabian Nietlispach

October 30, 2016

Presentation TCT 2016

Case #3: Leaflet Thrombosis Following Transcatheter Valve-in-Valve: Could It Have Been Prevented?

Presenter: Stanley J. Chetcuti, Susheel K. Kodali, Isaac George

October 30, 2016

Presentation TCT 2016

Case #2. Post-TAVR Paravalvulular Leak

Presenter: Eulogio J. Garcia, E. Murat Tuzcu, Reda Ibrahim

October 30, 2016

Presentation TCT 2016

Case #2: Transcatheter Valve-in-Valve in a Patient With a Small Aortic Bioprosthesis: Optimizing Hemodynamics

Presenter: Stanley J. Chetcuti, Susheel K. Kodali, Vasilis Babaliaros

October 30, 2016

Presentation TCT 2016

Case #1: Coronary Obstruction Following Transcatheter Valve in Valve: What I Learned

Presenter: Stanley J. Chetcuti, Susheel K. Kodali, Hasan Jilaihawi

October 30, 2016

Advertisement

The TAVR Development Journey: Lessons Learned and Drivers of Success

Intermediate-Risk Studies II: Updates From SURTAVI

Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials

Real-world Requirements and Expectations for TAVR in Lower Risk Patients

Flash Debate: Counterpoint - Guidelines Have Limited Value in Rapidly Evolving Transcatheter Valve Therapies!

Flash Debate: Point Guidelines Should Remain the Standard for Clinical Practice!

An Interesting Alternative: The New WikiRecs for TAVR Use in Lower Risk Patients

Future TAVR Guidelines: The Next ACC/AHA TAVR Focused Update and New Appropriate Use Criteria for TAVR

My Thoughts on TAVR Valve-in-Valve Procedures

Case Reviews: TAVR Valve-in-Valve

TAVR in Patients With Poor Femoral Access

Severe AS and Extreme Co-morbidities (Futile Patient?)

Case #5: Suboptimal Transcatheter Treatment of Failed Prior Surgical Mitral Repair

Management of Failing Aortic Bioprosthesis

Case #4: Transseptal Transcatheter Treatment of Failed Mitral Bioprosthesis (With Tips and Tricks)

TAVR in Patients With Atrial Fibrillation

Case #3: Leaflet Thrombosis Following Transcatheter Valve-in-Valve: Could It Have Been Prevented?

Case #2. Post-TAVR Paravalvulular Leak

Case #2: Transcatheter Valve-in-Valve in a Patient With a Small Aortic Bioprosthesis: Optimizing Hemodynamics

Case #1: Coronary Obstruction Following Transcatheter Valve in Valve: What I Learned

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content